catharanthine,
catharanthine monohydrochloride, (2alpha,5beta,6alpha,18beta)-isomer,
catharanthine sulfate, (2alpha,5beta,6alpha,18beta)-isomer,
Catharanthine,
2468-21-5,
UNII-WT0YJV846J,
WT0YJV846J,
CHEMBL2163793,
(+)-Catharanthine,
EINECS 219-586-6,
Ibogamine-18-carboxylic acid, 3,4-didehydro-, methyl ester, (2-alpha,5-beta,6-alpha,18-beta)-,
Methyl (2alpha,5beta,6alpha)-3,4-didehydroibogamine-18beta-carboxylate,
Catharanthine Base,
Methyl (2-alpha,5-beta,6-alpha,18-beta)-3,4-didehydroibogamine-18-carboxylate,
CHEBI:3469,
(+)-3, 4-Didehydrocoronaridine,
Catharanthine, >=95% (HPLC),
CMKFQVZJOWHHDV-NQZBTDCJSA-N,
HMS2095F15,
HMS3652A13,
HMS3712F15,
BDBM50396009,
MFCD01753356,
s3202,
ZINC57297068,
AKOS024463388,
CCG-220187,
ST24046287,
SW198653-2,
Q-9249,
AB01566866_01,
468C215,
Q-100319,
methyl (2alpha,18beta)-3,4-didehydroibogamine-18-carboxylate,
Ibogamine-18-carboxylic acid, 3,4-didehydro-, methyl ester, (2alpha,5beta,6alpha,18beta)-,
(1beta,4beta)-2,6-[Ethylene(1H-indole-3,2-diyl)]-7-ethyl-2-azabicyclo[2.2.2]octa-7-ene-6beta-carboxylic acid methyl ester,
Catharanthin,
(+)-3,4-Didehydrocoronaridine,
C21H24N2O2,
C21-H24-N2-O2,
ACN-056682,
CID5458190,
R101,
1013B,
(2-alpha,5-beta,6-alpha,18-beta)-3,4-Didehydroibogamine-18-carboxylic acid methyl ester,
Ibogamine-18-carboxylic acid, 3,4-didehydro-, methyl ester, (2.alpha.,5.beta.,6.alpha.,18.beta.)-,